Department of Sport Science, School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom.
Queen's Medical Centre Campus, Nottingham University Hospitals, Nottingham, United Kingdom.
Respir Care. 2021 Jun;66(6):972-975. doi: 10.4187/respcare.07848. Epub 2021 Mar 9.
Subjects with thoracic scoliosis were an important group in early studies of noninvasive ventilation (NIV). The aim of this study was to describe current rates of initiation of NIV and survival after initiation in this population.
This study included patients identified as having thoracic scoliosis and established between 1993 and 2018 on home NIV. Patients with scoliosis secondary to neuromuscular disease (other than poliomyelitis) were excluded. Survival rates were calculated for various time intervals up to 25 y.
A total of 53 subjects with thoracic scoliosis were successfully established on NIV. [Formula: see text] levels prior to starting NIV were 55 ± 23 mm Hg. FVC was 0.5 ± 0.1 L, 18.5 ± 9% of predicted, with a Cobb angle of 101 ± 3.5 degrees. The 5-, 10-, 15-, 20-, and 25-y survival rates were 96%, 88%, 61%, 46%, and 39%, respectively. At the time of death, subjects had been on home NIV for 9.2 ± 5.1 y and were 75.5 ± 9.2 y old. There was no significant correlation between mortality and age at time of commencing home NIV, initial arterial blood gas results, FVC, or Cobb angle. There was no significant difference in survival between those with and without poliomyelitis. In 8 of 10 of the most recent years of this survey, subjects with scoliosis have been commenced on home NIV.
Small numbers of subjects with scoliosis continued to present with respiratory failure. Once established on home NIV, around 40% survived ≥ 25 y. Long-term care will be needed for many years to come for this patient population.
在早期的无创通气(NIV)研究中,患有胸段脊柱侧凸的患者是一个重要群体。本研究的目的是描述该人群中 NIV 起始的当前发生率和起始后的生存率。
本研究纳入了 1993 年至 2018 年期间在家中接受 NIV 治疗的胸段脊柱侧凸患者。排除继发于神经肌肉疾病(除脊髓灰质炎外)的脊柱侧凸患者。计算了各种时间间隔(最长 25 年)的生存率。
共有 53 例胸段脊柱侧凸患者成功接受 NIV 治疗。开始 NIV 前的[Formula: see text]水平为 55 ± 23mmHg。FVC 为 0.5 ± 0.1L,占预计值的 18.5 ± 9%,Cobb 角为 101 ± 3.5 度。5、10、15、20 和 25 年的生存率分别为 96%、88%、61%、46%和 39%。死亡时,患者接受家庭 NIV 治疗的时间为 9.2 ± 5.1 年,年龄为 75.5 ± 9.2 岁。起始家庭 NIV 时的年龄、初始动脉血气结果、FVC 或 Cobb 角与死亡率之间无显著相关性。有无脊髓灰质炎患者的生存率无显著差异。在本研究最近的 10 年中的 8 年中,都有脊柱侧凸患者开始接受家庭 NIV。
少数脊柱侧凸患者仍出现呼吸衰竭。一旦在家中接受 NIV 治疗,约 40%的患者生存时间≥25 年。该患者群体在未来的许多年中都需要长期护理。